Revenue $2.91 billion $2.78 billion $2.52 billion 15.7% Net Income (non-GAAP) $1.04 billion N/A $1.10 billion (5.5%) R&D and SG&A expenses (non-GAAP) $1.21 billion N/A $984 million 22.9% Vertex ...

Vertex is faced with an access challenge as it is charging $15.50 for a 50 mg dose of Journavx, which works out to $420 for a two-week course. Generic opioids, meanwhile, go for roughly $0.50 a pill.

Vertex Pharmaceuticals beat expectations for revenue but missed on earnings. The company has two recent FDA approvals and several treatments in late-stage trials. The core CF treatments make up ...

Scotiabank raised the firm’s price target on Vertex Pharmaceuticals (VRTX) to $450 from $433 and keeps a Sector Perform rating on the shares. The company had a strong Q4, with revenue beating ...

1. Bentuk Parabola: Grafik fungsi kuadrat membentuk parabola yang simetris terhadap sumbu vertikal yang disebut sumbu simetri ...

Vertex has doubled down on cell-based therapies for type 1 diabetes (T1D), buying ViaCyte in a $320 million deal that it says will accelerate development of its own candidate VX-880. The deal has ...

Vertex Pharma could be close to succeeding in the long-standing quest to find an alternative to potentially addictive opioids for the treatment of pain associated with common medical procedures.

Bentuk dan ukuran dahi tidak hanya memengaruhi kesan visual seseorang, tetapi juga diyakini mencerminkan aspek-aspek mendalam dari kepribadian mereka. Setiap individu memiliki bentuk dahi yang unik, ...

Tim peneliti Universitas Pendidikan Ganesha (Undiksha) Singaraja, Bali mengembangkan produk konseling digital berbasis ... Penyedia layanan taksi berbasis mobil listrik asal Vietnam Xanh SM menargetka ...